/
/
/

Shree Ganesh Remedies Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2021Sep 2021Dec 2020Sep 2020
₹14 Cr₹33 Cr₹21 Cr₹30 Cr₹25 Cr₹24 Cr₹27 Cr₹32 Cr₹25 Cr₹37 Cr₹21 Cr₹17 Cr₹13 Cr₹12 Cr
₹94 L₹1 Cr₹66 L₹69 L₹66 L₹2 Cr₹71 L₹19 L₹55 L₹1 Cr₹88 L₹44 L₹55 L₹45 L
₹15 Cr₹34 Cr₹22 Cr₹31 Cr₹25 Cr₹27 Cr₹28 Cr₹33 Cr₹25 Cr₹39 Cr₹22 Cr₹17 Cr₹14 Cr₹12 Cr
₹13 Cr₹25 Cr₹17 Cr₹23 Cr₹20 Cr₹17 Cr₹20 Cr₹23 Cr₹19 Cr₹22 Cr₹16 Cr₹13 Cr₹10 Cr₹8 Cr
₹4 Cr₹12 Cr₹7 Cr₹10 Cr₹8 Cr₹12 Cr₹11 Cr₹11 Cr₹9 Cr₹18 Cr₹7 Cr₹5 Cr₹4 Cr₹5 Cr
₹32 L₹88 L₹74 L₹1 Cr₹94 L₹97 L₹39 L₹44 L₹32 L₹15 L₹3 L₹3 L₹2 L₹1 L
₹2 Cr₹9 Cr₹4 Cr₹7 Cr₹5 Cr₹9 Cr₹8 Cr₹9 Cr₹6 Cr₹16 Cr₹6 Cr₹4 Cr₹3 Cr₹4 Cr
₹1 Cr₹6 Cr₹3 Cr₹5 Cr₹3 Cr₹7 Cr₹5 Cr₹6 Cr₹5 Cr₹13 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr

Share Price Live Stats

Open (₹)686.50
Volume (₹)1,883.00
High (₹)696.20
Upper Circuit823.80
Low (₹)680.50
Lower Circuit549.20
Prev Close686.50
52W High (₹)759.00
Price696.20
52W Low (₹)381.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)881.30 Cr
Div. Yield (%)0.00
PE Ratio57.10
Debt to Equity0.19
Price to Book3.31
Book Value126.95
EPS (TTM)12.02
Face Value10.00
ROE (%)11.53

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SGRL-BNSE
LTP
1W Low
1W High
Market cap (₹)
1905.05-15.05 (-0.78%)
1901
1964.85
4,56,833Cr
9217.75-51.25 (-0.55%)
9051.85
9296
2,45,426Cr
4894.2-140.8 (-2.80%)
4884.05
5049
1,87,320Cr
1133.05-53.95 (-4.55%)
1126
1191.45
1,13,217Cr
1390.2-27.8 (-1.96%)
1377
1426.20
1,12,212Cr
1854-81.3 (-4.20%)
1812
1947.90
1,01,155Cr
2123.75-51.25 (-2.36%)
2117.80
2209
97,626Cr
2351.75-35.65 (-1.49%)
2323.15
2407.40
96,859Cr
1164.65-13.15 (-1.12%)
1155
1179.90
96,406Cr
1657.2+7.2 (0.44%)
1623.05
1706.70
93,614Cr
696.2+151.2 (27.74%)
561.65
700
881Cr

Key Highlights of Shree Ganesh Remedies Ltd’s P&L

In 2026-03-31, Shree Ganesh Remedies Ltd reported total revenue of ₹112.32Cr, compared with ₹112.33Cr in 2025-03-31, reflecting Shree Ganesh Remedies Ltd turnover.

Depreciation was ₹10.47Cr and finance costs were ₹3.56Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹24.01Cr in 2026-03-31 as compared to ₹31.27Cr in 2025-03-31.

Net Profit (PAT) was ₹17.76Cr in 2026-03-31 compared with ₹23.07Cr in 2025-03-31.

Earnings per share (EPS) were ₹13.83 in 2026-03-31, compared with ₹17.97 in 2025-03-31.